Loading...
Loading...
Holder clone rankings through .
Of the 18 tracked institutions holding ACAD, 8 have a 3-year clone track record — 6 of them beat the S&P. Average holder's clone alpha: +3.0pt. It's a gauge of who owns the name, not just how many.
Among the 18 tracked institutional investors we monitor, ACAD (ACADIA PHARMACEUTICALS INC) is held with a combined value of $2.03B across 95,862,268 shares. The largest holder is BAKER BROS. ADVISORS LP with a position worth $864.70M (4.11% of their portfolio). 2 funds opened new positions in the most recent quarter. 5 funds increased their holdings. 10 funds reduced their position.
Total Institutional Value
$2.03B
Total Shares Held
95,862,268
Institutional Holders
18
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | $864.70M | 4.11% | - |
| 2 | BlackRock, Inc. | $462.39M | 0.01% | +1.9% |
| 3 | VANGUARD GROUP INC | $404.76M | 0.01% | -0.2% |
| 4 | STATE STREET CORP | $154.17M | 0.00% | -15.7% |
| 5 | CITADEL ADVISORS LLC | $38.94M | 0.02% | -11.4% |
| 6 | Point72 Asset Management, L.P. | $22.89M | 0.04% | -53.3% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $22.32M | 0.03% | -13.7% |
| 8 | MILLENNIUM MANAGEMENT LLC | $16.03M | 0.01% | +34.8% |
| 9 | Fisher Asset Management, LLC | $14.33M | 0.00% | +1.7% |
| 10 | AQR CAPITAL MANAGEMENT LLC | $10.29M | 0.00% | -2.3% |
As of the latest SEC 13F filings, BAKER BROS. ADVISORS LP is the largest institutional holder of ACAD with a position worth $864.70M, representing 4.11% of their portfolio. In total, 18 institutional investors hold ACAD with a combined value of $2.03B.
In the most recent quarter, 2 funds opened a new position in ACAD. Additionally, 5 increased their holdings and 10 reduced their positions.
Institutional investors hold $2.03B worth of ACAD stock across 18 positions. The largest institutional holder is BAKER BROS. ADVISORS LP with $864.70M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ACAD, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
One weekly email with notable insider buys, sells and congressional disclosures. Unsubscribe anytime.
Alpha = the manager's 3-year clone return minus the S&P 500. A skilled roster is a stronger tell than a crowded one — though even skilled managers' edge doesn't reliably survive the 13F disclosure lag. Why →
| — |
| 5.3% |
| 2026-08-07 |
SEC Schedule 13D (activist) and 13G (passive) filings for ACAD. Filed when an investor acquires 5%+ ownership.
Last Close
$17.83
2026-11-18
YTD
-32.2%
9% of 52-week range